Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kaltura Inc (KLTR) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

Kaltura IncTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Kaltura Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Kaltura Inc trades at $1.38 (market cap $212.05M), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 41.8× Kaltura Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Kaltura Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kaltura Inc for 21 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

KLTRKYMR
Market Cap
$212.05M$8.87B
Volume
264,699779,107
Sector
TechnologyHealth
52-Week High
$1.89$127.31
52-Week Low
$1.08$55.80
Typical Hold Time
21 Days0 Days
Enterprise Value
$224.26M$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kaltura Inc

KLTR trades at $1.37, down 2.14% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages and oscillators. The company reported revenue of $180.85M in 2025, with a net loss of $12.07M, though losses have narrowed significantly from prior years. Recent news highlights include Gartner naming Kaltura a leader in AI for video platform services and a strategic partnership with Verimatrix for security.

The outlook remains speculative; while AI-driven growth and improving margins present upside potential, persistent losses, high valuation ratios, and negative cash flow pose substantial risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, but the stock's high volatility and weak profitability metrics warrant careful consideration.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KLTR

No sentiment data available yet.

KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About Kaltura Inc

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)

Read more on KLTR →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →